Every trade that managers of TelyRx Holdings Inc. disclose to SEDI is tracked on this page. In the past year (25 October 2025 to 25 October 2026), 16 filings came from 6 insiders.
Only purchases show up on the open market, 3 purchases in all worth €1.5M, filed by 2 insiders. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 1 major shareholder and 1 senior executive among the declarants. Atkins, Benjamin filed the largest purchase, €1.5M, on 16 September 2026.
The last purchase on record was published on 16 September 2026, which is 38 days ago. The median gap between a trade and its publication by SEDI is 5 days. Until a filing is published, the market cannot know about the trade.
Compared with its exchange (2,120 companies, median 12 filings), a count of 16 filings is above the norm. Our records for TelyRx Holdings Inc. go back to 2026, with 3 purchases and no sales on the open market in total.
Source: insider filings from SEDI. Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
16 of 16 declarations
TelyRx Holdings Inc. is a company listed on the Toronto Stock Exchange, focused on developing digital health solutions. It aims to enhance access to care and patient engagement.